A report issued by the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) urges better oversight for genetic tests. The panel, commissioned by the US Department of Health and Human Services, identifies various gaps in the regulation of genetic testing and calls for better coordination between federal, state and other agencies to improve the oversight model. SACGHS members also recommend that public and private sectors adopt measures to assure public health and safety when conducting and interpreting results from clinical genetic testing. Although mandated to review the validity and utility of genetic testing, the panel recognizes that their recommendations “could well be applied more broadly to improve the quality of all laboratory tests.” Indeed, they call on the US Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS)—the two federal agencies with principal regulatory authority over genetic testing—to overhaul clinical testing with “establishment of a mandatory test registry.” The panel also urges the FDA “to strengthen monitoring and enforcement efforts against laboratories and companies that make false and misleading claims about laboratory tests, including direct-to-consumer tests.”